Milad Alucozai

Co-Founder & General Partner, Pamir Ventures

Dr. Milad Alucozai is a biotech executive, computational neuroscientist, founder, and investor dedicated to translating frontier science into scalable platforms that advance human health. Recognized by Business Insider as one of the top 100 early-stage investors, he co-founded Pamir Ventures with Roger Ferguson, former Vice Chair of the U.S. Federal Reserve, to serve as the first check and full-stack partner to technical pioneers redefining markets. He also serves as an External Advisor to Amgen.

Milad is also Co-Founder of Revalia Bio, a company that revives donated human organs and transforms them into foundational models for biomedical research. By integrating medicine, engineering, and data science, Revalia generates earlier, more human-relevant data to accelerate drug development and lower costs. Across his career, he has helped companies raise hundreds of millions in venture capital and supported billions in startup-pharma partnerships and co-development deals.

He supported $1.5 billion in ARPA-H funding and previously advised AstraZeneca. He is the creator of the BITS (Bio-Industrial Technology Stack) framework, which reframes biology as a geopolitical and industrial asset. A National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine, Dr. Alucozai graduated Phi Beta Kappa in Neuroscience from Purdue’s Honors Program, earned a master’s in Immunology and Public Health as a US-Ireland Alliance Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. He completed a Visiting Scholar appointment at the Wyss Institute for Biologically Inspired Engineering at Harvard University.